Moreover, a patent of a luteolin pharmaceutical composition from the USA has treated and prevented the cancerous cells of liver, brain, pancreas, lung, breast cancer, and leukemia via targeting the BCL-2, bromodomains, sirtuins, kinases, and matrix metalloproteinases. The gene discussed is BCL2; the disease is breast cancer.